Senzime presents clinical study with OneSenz
Uppsala, Sweden, 23 June 2015. Senzime AB (publ) today announces that the company's analytical instrument, OneSenz, is evaluated in clinical research, the purpose of which was to demonstrate OneSenz’s capacity to monitor glucose levels automatically and continuously during glucose load in individuals in a research study. The evaluation has been undertaken in collaboration with Uppsala University and was completed during the spring 2015.Senzime develops the analytical instrument, OneSenz, which automatically and continuously monitors the patient's blood-sugar level online. The instrument’s